For research use onlyNot for human consumptionPurchasers must be 21+
Manufacturer COA available on requestBioregulator presale open · Lot 002
WAVE RESEARCH LABS PEPTIDES · BIOREGULATORS EST. 2026 SMALL BATCH
Wave Research Labsest. 2026 · peptides & bioregulators
Search compounds
Cart0
Wave Research Labs
est. 2026 · peptides & bioregulators

Short chains,
precise signals.

Peptides are short chains of amino acids joined by peptide bonds, and many act as signaling molecules that bind specific receptors. Bioregulators are among the shortest, two to seven residues, studied for how they interact with DNA and chromatin and influence gene expression in particular tissues.

For research use only. Not for human consumption.Sold to qualified researchers for laboratory and in-vitro use. We do not provide dosing or medical advice.
Engraving of apothecary glassware on a shelf
the current shelffor laboratory research
compendium · entry iiichemistry only

SS-31 elamipretide

class
tetrapeptide
mol. weight
639.8 g/mol
cas no.
736992-21-5
D-Arg-Dmt-Lys-Phe-NH₂ · a Szeto–Schiller peptide.Read entry ↗
in every compendium entry —originclasssequenceformula & masscas no.
The Current Shelf

Choose a compound.
Learn more.

Each label gives the compound, its vial size and form.

sampleEngraved vial
no. 01est. 2026
Wave Research Labs

MOTS-c

40 mg · lyophilized
lot
WRL-2611-MOT4
purity
99.3% rep.
Check mechanism →
for research use only.
not for human consumption.
$65.00sampleAdd to cart
sampleEngraved vial
no. 02est. 2026
Wave Research Labs

Tesamorelin

20 mg · lyophilized
lot
WRL-2611-TES20
purity
99.1% rep.
Check mechanism →
for research use only.
not for human consumption.
$96.00sampleAdd to cart
sampleEngraved vial
no. 03est. 2026
Wave Research Labs

SS-31

50 mg · lyophilized
lot
WRL-2611-SS50
purity
99.5% rep.
Check mechanism →
for research use only.
not for human consumption.
$95.00sampleAdd to cart
sampleEngraved vial
no. 04est. 2026
Wave Research Labs

Thymosin
Alpha-1

10 mg · lyophilized
lot
WRL-2611-TA10
purity
99.2% rep.
Check mechanism →
for research use only.
not for human consumption.
$43.00sampleAdd to cart
sampleEngraved vial
no. 05est. 2026
Wave Research Labs

KPV

30 mg · lyophilized
lot
WRL-2611-KPV3
purity
99.4% rep.
Check mechanism →
for research use only.
not for human consumption.
$71.00sampleAdd to cart
sampleEngraved vial
no. 06est. 2026
Wave Research Labs

Ipamorelin

10 mg · lyophilized
lot
WRL-2611-IPA10
purity
99.4% rep.
Check mechanism →
for research use only.
not for human consumption.
$37.00sampleAdd to cart
sampleEngraved vial
no. 07est. 2026
Wave Research Labs

NA-Selank

10 mg · N-acetyl amidate
lot
WRL-2611-SEL10
purity
99.0% rep.
Check mechanism →
for research use only.
not for human consumption.
$46.00sampleAdd to cart
sampleEngraved vial
no. 08est. 2026
Wave Research Labs

NA-Semax

10 mg · N-acetyl amidate
lot
WRL-2611-SEM10
purity
99.2% rep.
Check mechanism →
for research use only.
not for human consumption.
$39.00sampleAdd to cart
coming soon to the shelf
Engraved vial
no. 09est. 2026
Wave Research Labs

BPC-157

10 mg · lyophilized
lot
pending
purity
—
Check mechanism →
for research use only.
not for human consumption.
Coming soonNotify me
Engraved vial
no. 10est. 2026
Wave Research Labs

TB-500

10 mg · lyophilized
lot
pending
purity
—
Check mechanism →
for research use only.
not for human consumption.
Coming soonNotify me
Engraved vial
no. 11est. 2026
Wave Research Labs

GHK-Cu

50 mg · lyophilized
lot
pending
purity
—
Check mechanism →
for research use only.
not for human consumption.
Coming soonNotify me
bioregulators · presale · ships with lot 002

Seven short-peptide bioregulators, open for pre-order. Each label links to its mechanism and pathway in Compendium Vol. II.

vol. ii · ipresale
Wave Research Labs

Thymulin

10 mg · lyophilized
length
9 residues
ships
with Lot 002
Check mechanism & pathway →
for research use only.
not for human consumption.
$58samplePre-order
vol. ii · iipresale
Wave Research Labs

Vesugen

20 mg · lyophilized
length
3 residues
ships
with Lot 002
Check mechanism & pathway →
for research use only.
not for human consumption.
$48samplePre-order
vol. ii · iiipresale
Wave Research Labs

Thyreogen

20 mg complex · lyophilized
length
mixture
ships
with Lot 002
Check mechanism & pathway →
for research use only.
not for human consumption.
$52samplePre-order
vol. ii · ivpresale
Wave Research Labs

Pinealon

20 mg · lyophilized
length
3 residues
ships
with Lot 002
Check mechanism & pathway →
for research use only.
not for human consumption.
$46samplePre-order
vol. ii · vpresale
Wave Research Labs

Epitalon

50 mg · lyophilized
length
4 residues
ships
with Lot 002
Check mechanism & pathway →
for research use only.
not for human consumption.
$62samplePre-order
vol. ii · vipresale
Wave Research Labs

Ovagen

20 mg · lyophilized
length
3 residues
ships
with Lot 002
Check mechanism & pathway →
for research use only.
not for human consumption.
$46samplePre-order
vol. ii · viipresale
Wave Research Labs

Vilon

20 mg · lyophilized
length
2 residues
ships
with Lot 002
Check mechanism & pathway →
for research use only.
not for human consumption.
$46samplePre-order
The Compendium

What each compound is,
in plain terms.

Chemistry and history only. Each entry summarizes published research literature for reference. Nothing here is a claim about use.

Compendium · Vol. I · PeptidesEleven entries · eight in stock, three coming soon
For research use only
Entry I

MOTS-c

Mitochondrial open reading frame of the 12S rRNA-c
Mitochondrial-derived peptide

A short peptide encoded within the mitochondrial genome, in the gene for 12S ribosomal RNA (MT-RNR1). It is studied in cell and animal models for its role in metabolic signalling between the mitochondria and the nucleus.

Origin. Described in 2015 by Changhan Lee and colleagues in the Pinchas Cohen laboratory, University of Southern California.

length
16 residues
formula
C₁₀₁H₁₅₂N₂₈O₂₂S₂
mol. weight
2174.6 g/mol
cas no.
1627580-64-6
sequence
MRWQEMGYIFYPRKLR
Entry II

Thymosin Alpha-1

TA1 · Thymalfasin
Thymic peptide, N-acetylated

A fragment of the larger precursor protein prothymosin alpha, and the first peptide from thymosin fraction 5 to be fully sequenced and synthesized. Its interactions with immune-cell receptors, including toll-like receptors, are a long-standing subject of immunology research.

Origin. Isolated from thymosin fraction 5 and sequenced by Allan Goldstein, Teresa Low and colleagues, 1977.

length
28 residues
formula
C₁₂₉H₂₁₅N₃₃O₅₅
mol. weight
3108.3 g/mol
cas no.
62304-98-7
sequence
Ac-SDAAVDTSSEITTKDLKEKKEVVEEAEN
Entry III

SS-31

Elamipretide · MTP-131
Synthetic mitochondria-targeted tetrapeptide

A small aromatic-cationic peptide containing the unnatural residue 2′,6′-dimethyltyrosine (Dmt). It concentrates at the inner mitochondrial membrane, where its binding to the phospholipid cardiolipin is a principal focus of research.

Origin. One of the Szeto–Schiller peptides, named for Hazel Szeto and Peter Schiller; reported as mitochondria-targeted by Zhao, Szeto and colleagues, 2004.

length
4 residues
formula
C₃₂H₄₉N₉O₅
mol. weight
639.8 g/mol
cas no.
736992-21-5
sequence
D-Arg-Dmt-Lys-Phe-NH₂
Entry IV

Tesamorelin

TH9507 · trans-3-hexenoyl-GHRH(1–44) amide
Synthetic GHRH analog

The full 44-residue sequence of human growth-hormone-releasing hormone, with a trans-3-hexenoyl group added at the N-terminus. The modification makes it more resistant to cleavage by dipeptidyl peptidase than the native hormone. It acts on the GHRH receptor of the pituitary.

Origin. Developed by Theratechnologies, Montréal, Canada.

length
44 residues
formula
C₂₂₁H₃₆₆N₇₂O₆₇S
mol. weight
5135.9 g/mol
cas no.
218949-48-5
sequence
trans-3-hexenoyl-YADAIFTNSYRKVLGQLSARKLLQDIMSRQQGESNQERGARARL-NH₂
Entry V

Ipamorelin

NNC 26-0161
Ghrelin-receptor agonist · growth hormone secretagogue

A synthetic pentapeptide that binds the growth hormone secretagogue receptor (GHS-R1a), the receptor for ghrelin. In early animal studies it was characterized by its selectivity, with little measured effect on ACTH or cortisol.

Origin. Developed at Novo Nordisk, derived from GHRP-1; described by Raun and colleagues, 1998.

length
5 residues
formula
C₃₈H₄₉N₉O₅
mol. weight
711.9 g/mol
cas no.
170851-70-4
sequence
Aib-His-D-2Nal-D-Phe-Lys-NH₂
Entry VI

KPV

Lys-Pro-Val · α-MSH (11–13)
Melanocortin-derived tripeptide

The last three residues of α-MSH, studied as a free tripeptide. In intestinal epithelial and T-cell lines it is taken up by the di/tripeptide transporter PepT1, and at nanomolar concentrations it is reported to inhibit NF-κB and MAP kinase activation in cell and mouse models of inflammation.

Origin. The C-terminal tripeptide (residues 11–13) of α-melanocyte-stimulating hormone. Its transport by PepT1 was characterized by Dalmasso, Merlin and colleagues, Emory University, 2008.

length
3 residues
formula
C₁₆H₃₀N₄O₄
mol. weight
342.4 g/mol
cas no.
67727-97-3
sequence
H-Lys-Pro-Val-OH
Entry VII

NA-Selank

N-acetyl Selank amidate · Ac-TKPRPGP-NH₂
Synthetic heptapeptide · tuftsin analog

Selank is the immunopeptide tuftsin (Thr-Lys-Pro-Arg) extended with Pro-Gly-Pro. In published work on the unmodified peptide it inhibits enkephalin-degrading peptidases in plasma, and in rat frontal cortex it alters the expression of genes involved in GABAergic neurotransmission.

Origin. Selank was developed at the Institute of Molecular Genetics, Russian Academy of Sciences, Moscow (Nikolai Myasoedov and colleagues). This form adds an N-terminal acetyl group and a C-terminal amide.

length
7 residues
formula
C₃₅H₆₀N₁₂O₉
mol. weight
792.9 g/mol
cas no.
—
sequence
Ac-Thr-Lys-Pro-Arg-Pro-Gly-Pro-NH₂
Entry VIII

NA-Semax

N-acetyl Semax amidate · Ac-MEHFPGP-NH₂
Synthetic heptapeptide · ACTH(4–7) analog

Semax joins the adrenocorticotropin fragment ACTH(4–7) to a C-terminal Pro-Gly-Pro. In rat studies of the unmodified peptide it raises hippocampal BDNF levels and TrkB phosphorylation, and alters transcription of neurotrophin and Trk receptor genes.

Origin. Semax was developed at the Institute of Molecular Genetics, Russian Academy of Sciences, Moscow (Nikolai Myasoedov and colleagues). This form adds an N-terminal acetyl group and a C-terminal amide.

length
7 residues
formula
C₃₉H₅₄N₁₀O₁₀S
mol. weight
855.0 g/mol
cas no.
2920938-90-3
sequence
Ac-Met-Glu-His-Phe-Pro-Gly-Pro-NH₂
coming soon to the shelf
Entry IX

BPC-157

Body protection compound 157 · pentadecapeptide
Gastric-juice-derived pentadecapeptide
coming soon

A 15-residue partial sequence of “body protection compound”, a protein described in human gastric juice. In endothelial cell studies it is reported to activate the VEGFR2–Akt–eNOS signalling pathway, and in tendon fibroblasts to increase FAK and paxillin phosphorylation.

Origin. Described by Predrag Sikirić and colleagues as a partial sequence of a protein from human gastric juice, first reported in the early 1990s.

length
15 residues
formula
C₆₂H₉₈N₁₆O₂₂
mol. weight
1419.5 g/mol
cas no.
137525-51-0
sequence
H-Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val-OH
Entry X

TB-500

Ac-LKKTETQ · thymosin β4 (17–23)
N-acetylated synthetic heptapeptide
coming soon

A synthetic, N-acetylated copy of the LKKTETQ segment of thymosin β4, the major actin-sequestering protein of eukaryotic cells. Residues 17–23 form the central actin-binding site of the parent protein, which cell studies associate with actin binding and cell migration.

Origin. Derived from thymosin β4, a 43-residue protein found in essentially all cells and body fluids.

length
7 residues
formula
C₃₈H₆₈N₁₀O₁₄
mol. weight
889.0 g/mol
cas no.
885340-08-9
sequence
Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln-OH
Entry XI

GHK-Cu

Gly-His-Lys · copper(II) complex
Tripeptide–copper complex
coming soon

A tripeptide first reported in human serum that binds copper(II). The structure of the copper complex in solution has been studied by spectroscopy, and in fibroblast cultures the complex is reported to stimulate collagen synthesis.

Origin. The tripeptide was first reported in human serum by Loren Pickart and Melvin Thaler, 1973.

length
3 residues
formula
C₁₄H₂₂CuN₆O₄
mol. weight
401.9 g/mol
cas no.
89030-95-5
sequence
H-Gly-His-Lys-OH · Cu²⁺
Sources: PubChem and primary literature, cited on each compound page.Molecular weights are averages for the free peptide.
Continue to Vol. II · Bioregulators ↓
The Compendium · Vol. II

The short peptides
of St. Petersburg.

Seven short-peptide bioregulators: chemistry, mechanism and pathway as reported in published research. Nothing here is a claim about use. Back to the presale shelf ↑

Compendium · Vol. II · BioregulatorsSeven entries · mechanism & pathway
For research use only
Entry I

Thymulin

Facteur thymique sérique (FTS) · serum thymic factor
Thymic nonapeptide · zinc-dependent

A circulating thymic peptide first isolated from pig serum, with an N-terminal pyroglutamate. It is the oldest entry in this volume and the only one discovered outside the St. Petersburg program.

Mechanism. Biologically active only when bound to zinc. NMR and antibody studies describe a distinct zinc-coupled conformation, and the peptide was first characterized through its effect on T-cell differentiation markers.

Pathway. Reported in animal and cell models to reduce p38 MAPK phosphorylation and NF-κB signalling in inflammation models.

Origin. Isolated and sequenced by Mireille Dardenne, Jean-Marie Pléau, Jean-François Bach and colleagues, Paris, 1977.

length
9 residues
formula
C₃₃H₅₄N₁₂O₁₅
mol. weight
858.9 g/mol
cas no.
78922-62-0
sequence
pGlu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn-OH
Entry II

Vesugen

KED · Lys-Glu-Asp
Khavinson short peptide bioregulator · tripeptide

A synthetic tripeptide from the St. Petersburg bioregulator program, catalogued by its developers as a vascular-tissue peptide.

Mechanism. Proposed to enter the nucleus and bind DNA. In cell-culture studies it is reported to change expression of the senescence genes p16 and p21 and of the differentiation markers nestin and GAP43.

Pathway. Cell-senescence (p16/p21) and differentiation-factor signalling, including CXCL12 in fibroblast cultures.

Origin. Vladimir Khavinson and colleagues, St. Petersburg Institute of Bioregulation and Gerontology.

length
3 residues
formula
C₁₅H₂₆N₄O₈
mol. weight
390.4 g/mol
cas no.
204271-66-9
sequence
H-Lys-Glu-Asp-OH
Entry III

Thyreogen

Peptide complex A-2 · thyroid cytomax
Cytomax · tissue-derived peptide complex

Not a single synthetic peptide. It is a peptide complex extracted from the thyroid tissue of young calves, and no defined amino-acid sequence has been published for it.

Mechanism. Described by its developers within the same short-peptide gene-regulation model as the synthetic bioregulators. Thyroid-specific mechanistic data in the indexed literature are limited.

Pathway. Not established in published literature.

Origin. St. Petersburg Institute of Bioregulation and Gerontology (Khavinson program).

length
mixture
formula
not defined
mol. weight
not defined
cas no.
—
sequence
No single defined sequence (peptide complex)
Entry IV

Pinealon

EDR · Glu-Asp-Arg
Khavinson short peptide bioregulator · tripeptide

A synthetic tripeptide catalogued by its developers among the nervous-tissue peptides, and one of the most studied of the short bioregulators in cell models.

Mechanism. Modelled to partly enter the major groove of DNA, which is aided by Mg²⁺ ions. In cerebellar granule cells it is reported to limit the build-up of reactive oxygen species and to alter the cell cycle.

Pathway. Delayed ERK1/2 (MAPK/ERK) activation, with reported effects on caspase-3, p53, SOD2 and GPX1 expression.

Origin. Vladimir Khavinson and colleagues, St. Petersburg Institute of Bioregulation and Gerontology.

length
3 residues
formula
C₁₅H₂₆N₆O₈
mol. weight
418.4 g/mol
cas no.
175175-23-2
sequence
H-Glu-Asp-Arg-OH
Entry V

Epitalon

AEDG · Epithalon · Ala-Glu-Asp-Gly
Khavinson short peptide bioregulator · tetrapeptide

A tetrapeptide designed from the amino-acid analysis of a pineal-gland (epiphysis) peptide complex. AEDG was later detected among that complex’s own tetrapeptides.

Mechanism. Reported to bind histones H1/3 and H1/6, and modelled to bind a DNA sequence that recurs in the telomerase promoter region.

Pathway. Telomerase activity and telomere length in human fetal fibroblast cultures.

Origin. Vladimir Khavinson and colleagues, St. Petersburg Institute of Bioregulation and Gerontology.

length
4 residues
formula
C₁₄H₂₂N₄O₉
mol. weight
390.35 g/mol
cas no.
307297-39-8
sequence
H-Ala-Glu-Asp-Gly-OH
Entry VI

Ovagen

EDL · Glu-Asp-Leu
Khavinson short peptide bioregulator · tripeptide

A synthetic tripeptide, structurally Bronchogen (AEDL) without its first alanine. Its indexed cell studies use renal cell cultures.

Mechanism. Docking models place it in the minor groove of DNA at AT-rich sequences, and at ctcc sites shared with AEDL.

Pathway. Senescence markers p16, p21 and p53, and SIRT-6 expression, in ageing renal cell culture.

Origin. Vladimir Khavinson and colleagues; described in a 2006 Russian patent filing.

length
3 residues
formula
C₁₅H₂₅N₃O₈
mol. weight
375.4 g/mol
cas no.
—
sequence
H-Glu-Asp-Leu-OH
Entry VII

Vilon

KE · Lys-Glu · AB-0
Khavinson short peptide bioregulator · dipeptide

A synthetic dipeptide from the St. Petersburg bioregulator program, studied mainly in thymic and lymphocyte cell cultures. It is the smallest entry in this volume.

Mechanism. Reported to decondense facultative heterochromatin in cultured lymphocytes, including the nucleolus organizer regions. Docking models place KE at agat sequences of DNA.

Pathway. Ribosomal-gene reactivation through chromatin decondensation, and expression of the T-cell differentiation markers CD5 and CD4 in thymic cell cultures.

Origin. Vladimir Khavinson and colleagues, St. Petersburg Institute of Bioregulation and Gerontology.

length
2 residues
formula
C₁₁H₂₁N₃O₅
mol. weight
275.3 g/mol
cas no.
45234-02-4
sequence
H-Lys-Glu-OH
Sources: PubChem and primary literature, cited on each compound page. Mechanisms are as proposed or reported in cell, animal and modelling studies.Presale · ships with Lot 002
The Primer · I

What is a peptide?

Four ideas that sit behind every entry in the compendium.

I

Amino acids

The building blocks. Each has an amino group, a carboxyl group and a side chain that gives it its own size, charge and polarity.

II

The peptide bond

A condensation reaction joins the carboxyl group of one amino acid to the amino group of the next, releasing water and forming the –CO–NH– link.

III

Sequence & fold

The order of residues, read from N- to C-terminus, sets a chain’s charge and the shapes it can take, from flexible short chains to folded helices.

IV

Receptor binding

Many signaling peptides work by fitting a specific receptor, often on the cell surface, which sets off a cascade of signals inside the cell.

Reading a sequence

Every sequence in the compendium is written from the N-terminus to the C-terminus in three- or one-letter amino-acid codes. Ac- marks an acetylated N-terminus, and -NH₂ marks a C-terminal amide.

The Primer · II

Peptides & bioregulators.

Both are short chains of amino acids. They differ in length and origin, and in where their action is thought to begin.

Side by sideAs described in the published research literature
Chemistry only
Signaling peptidesShort-peptide bioregulators
LengthRanges widely. The compounds on our shelf run from 3 to 44 residues.Two to seven residues. Vilon (Lys-Glu) is a dipeptide.
OriginHormone fragments, analogs and synthetic designs, such as ACTH(4–7)-Pro-Gly-Pro or GHRH(1–44).Designed from amino-acid analyses of tissue peptide extracts by Vladimir Khavinson and colleagues, St. Petersburg.
Primary targetReceptors, often on the cell surface: the GHRH receptor, the ghrelin receptor (GHS-R1a), the PepT1 transporter.Proposed to cross the cell and nuclear membranes and interact with histones and DNA.
Proposed mode of actionReceptor binding starts an intracellular signaling cascade.Hypothesized to bind specific DNA sequences in gene promoters, affect chromatin structure and DNA methylation, and shift gene expression in a tissue-specific way.
Kind of evidenceReceptor, cell and animal studies across many laboratories.Mostly cell-culture, molecular-docking and animal studies, largely from the St. Petersburg group and its collaborators.
Examples hereTesamorelin · Ipamorelin · KPV · NA-SemaxEpitalon · Vilon · Pinealon · Vesugen
Sources: PubChem and primary literature, listed in the compendium notes.Mechanisms are as proposed or reported in published studies.
About the House

A small house.
A short shelf.

Wave Research Labs is a small-batch supplier of research peptides. We keep the shelf short on purpose, so every compound on it can be described properly and handled with care from receipt to shipment.

  • i.A short shelf, restocked in small runs
  • ii.Every compound described by its chemistry and history
  • iii.Orders packed and shipped by us
  • iv.Research use only. No health claims, no dosing advice
on the benchform wrl-02

Storage & handling.

Form
Lyophilized powder, sealed vial
Long-term
−20 °C, dry, protected from light
Short-term
2–8 °C, unopened
Before opening
Let the vial reach room temperature
Shipping
Padded, sealed and labelled by lot
Intended use
Laboratory & in-vitro research only

General guidance for lyophilized peptides.

Questions

Answered plainly.

We can help with compounds, certificates and orders. We can’t advise on dosing or any medical use.

hello@waveresearchlabs.com(000) 000-0000 · Mon–Fri placeholder
Are your products for human use?

No. Every Wave Research Labs product is sold strictly for laboratory and in-vitro research by qualified researchers. They are not drugs, supplements or cosmetics, are not for human or animal consumption, and have not been evaluated by the FDA to diagnose, treat, cure or prevent any disease.

Can I see a certificate of analysis?

Yes. The manufacturer’s certificate of analysis for any compound we carry is available on request. Send us the compound name and we’ll email it to you.

What is the difference between a peptide and a bioregulator?
How are orders packed and shipped?
Where does the compendium information come from?
Engraving of a breaking wave

Wave Research Labs · Peptides & Bioregulators